Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drug Information Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Drug-induced immune hemolytic anemia

Printer-friendly versionEmail this page to a friend
Contents of this page:

Illustrations

Antibodies
Antibodies

Alternative names    Return to top

Immune hemolytic anemia secondary to drugs; Anemia - immune hemolytic - secondary to drugs

Definition    Return to top

Drug-induced immune hemolytic anemia is an acquired form of hemolytic anemia caused by interaction of certain drugs with the immune system. The result is the production of antibodies against the red blood cells and premature red blood cell destruction.

Causes, incidence, and risk factors    Return to top

Drug-induced immune hemolytic anemia occurs when certain drugs start an immune reaction against red blood cells. In some instances, the drugs interact with the red blood cell membrane, causing the cell to become antigenic. This means the body identifies these cells as not belonging to the body. Antibodies form against the red blood cells. The antibodies attach to red blood cells and result in their premature destruction. This condition is rare in children.

Drugs that can cause immune hemolytic anemia include the following:

There are many other rarer causes of drug-induced hemolytic anemia. Drug-induced hemolytic anemia is most often associated with G6PD deficiency. However, G6PD deficiency and hemolysis is due to oxidative stress in the red cell, not an autoimmune phenomenon.

Symptoms    Return to top

Signs and tests    Return to top

A physical examination may show an enlarged spleen. Other tests may indicate drug-induced immune hemolytic anemia.

Treatment    Return to top

Discontinuation of the suspected causative drug may relieve or control the symptoms. Treatment with prednisone is the first additional therapy that may be tried.

Blood transfusions with carefully typed packed red blood cells may be advised for severe symptoms.

Expectations (prognosis)    Return to top

The outcome is expected to be good. The process subsides when the offending agent is eliminated from the body.

Complications    Return to top

Calling your health care provider    Return to top

See your health care provider any time that dark urine and jaundice occur, particularly if other symptoms also develop after taking a medication.

Prevention    Return to top

If the disorder occurs, the individual should avoid the offending drug and its analogues (similar medications) in the future.

Update Date: 8/18/2003

Updated by: Corey Cutler, M.D., M.P.H., F.R.C.P.C., Department of Medical Oncology, Dana-Farber Cancer Institute; Instructor in Medicine, Harvard University, Boston, MA. Review provided by VeriMed Healthcare Network.

adam.com logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2002 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.